The SARS-CoV-2 trigger highlights host interleukin 1 genetics in Epstein-Barr virus reactivation

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F25%3A73633208" target="_blank" >RIV/61989592:15110/25:73633208 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/25:00141743 RIV/65269705:_____/25:00082173
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S2211124725006308?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2211124725006308?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.celrep.2025.115859" target="_blank" >10.1016/j.celrep.2025.115859</a>

Result language
angličtina
Original language name
The SARS-CoV-2 trigger highlights host interleukin 1 genetics in Epstein-Barr virus reactivation
Original language description
Host interleukin-1 genetics predisposes individuals to EBV reactivation during COVID-19, and EBV reactivation during SARS-CoV-2 infection contributes to pulmonary long COVID. High latent EBV loads in blood are associated with long-term lung impairment in long COVID. Anti-VCA IgA serum levels are a strong marker of recent EBV reactivation.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30102 - Immunology

Project
<a href="/en/project/NU22-A-105" target="_blank" >NU22-A-105: Predicitve biomarkers of therapeutic response on COVID-19 therapy</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)